Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Wyeth cuts collaboration ties with Curis Inc.
March 2008
SHARING OPTIONS:

CAMBRIDGE, Mass.Curis Inc., a drug development company focused on developing novel targeted medicines primarily for cancer treatment, announced that Wyeth has decided it will no longer pursue development efforts on the Hedgehog agonist program and will terminate the January 2004 collaboration agreement with Curis. Research efforts under the collaboration have focused on the preclinical development of small molecule and protein Hedgehog agonists, primarily for stroke and cardiovascular indications. Pursuant to the agreement, the collaboration will conclude on May 6.
 

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.